The opportunistic fungus C. albicans is the most important fungus in the case of oral and deep-seated infections. Adsorption, dimorphism and enzyme production are reported as pathogenic factors of C. albicans. 1, 2) The yeast to hyphal transformation of C. albicans is influenced by environmental conditions, and the pathogenesis of the hyphal form is stronger than the yeast form.
The opportunistic fungus C. albicans is the most important fungus in the case of oral and deep-seated infections. Adsorption, dimorphism and enzyme production are reported as pathogenic factors of C. albicans. 1, 2) The yeast to hyphal transformation of C. albicans is influenced by environmental conditions, and the pathogenesis of the hyphal form is stronger than the yeast form. 3) C. albicans exists in yeast form on the skin and mucous membrane and then invades the tissue in hyphal form. RAS1 is known as a signal transduction factor related to hyphal formation. 4) MAP kinase cascade and cAMP signaling pathway have been reported as the hyphal formation signal of C. albicans and is regulated by RAS1.
5) The RAS-cAMP pathway requires functional EFG1, which leads to enhanced filamentous growth. 6) Mucin is the main glycoprotein of mucus and covers the inner cavities such as the trachea, stomach and intestines. Salivary mucin comprises protein, N-acetylglucosamine, Nacetylgalactosamine, galactose, fucose, mannose and Nacetylneuraminic acid. 7) It is known that salivary mucin adheres to C. albicans and inhibits the adherence of C. albicans to the mucous membrane. 8) Moreover, mucin exhibits antifungal activity. 9) In this report, we demonstrate that mucin inhibits the hyphal formation of C. albicans.
MATERIALS AND METHODS

Reagents
Mucin from bovine submaxillary glands (Sigma, U.S.A.; M4503) was used in this study.
Strain and Culture Conditions C. albicans NIH A-207 yeast cells was maintained at 27°C in Sabouraud's medium (2% glucose, 1% peptone and 0.5% yeast extract) with shaking for 24 h. After the incubation, the yeast cells were washed with sterilized water, then suspended in RPMI1640 medium (Nissui Pharmaceutical Co., Ltd.). The cells were incubated without shaking at 37°C in 5% CO 2 to induce hyphal form.
Effect of Mucin on the Hyphal Formation of C. albicans C. albicans NIH A-207 (1ϫ10 5 cells/ml in RPMI1640 medium) was incubated with mucin at 37°C in 5% CO 2 . After incubation, the ratio of the hyphal cells was measured. Briefly, the number of yeast cells was calculated by hemocytometer, and the total number of cells was measured by absorbance at OD 620 . The accuracy of this measurement was verified using NucleoCounter TM YC-100 (MC Techono Systems). NucleoCounter TM YC-100 can count the amount of nucleus and converted into the number of cells. When the number of hyphal cells of C. albicans was counted using this system, the resulted number was similar to the number calculated from the absorbance (data not shown). The ratio of hyphal cells was calculated using the following formula: the ratio of hyphal cellsϭ[(total number of cellsϪnumber of yeast cells)/total number of cells]ϫ100. The growth form of C. albicans cells was photographed with an IX51 microscope (Olympus Co.). Growth curves were monitored spectrophotometrically by the absorbance at OD 620 every hour until 6 h.
Amount of RAS1mRNA in C. albicans C. albicans (1ϫ10 5 cells/ml in RPMI1640 medium) was incubated with mucin (1000 mg/ml) at 37°C in 5% CO 2 . After incubation, the cells were harvested by centrifugation, and crushed using a Mini Bead-Beater (Central Scientific Commerce, Inc.) with glass beads (0.5 mm). Total RNA was extracted by a Total RNA purification kit, MagExtractor (Toyobo Co., Ltd.). The total RNA was mixed with dNTP Mix (Toyobo Co., Ltd.) and random hexamers (Roche Ltd., Switzerland), then incubated at 70°C for 3 min. M-MLV Reverse Transcriptase (Ambion Inc., U.S.A.), 10ϫRT buffer (Ambion Inc.) and RNase inhibitor (Promega Co., U.S.A.) were added to this mixture and incubated at 42°C for 1 h. The reaction was terminated by heating at 92°C for 10 min, and the resulting mixture was used as a cDNA solution. The relative expression of RAS1mRNA in cDNA was analyzed by a 7500 Real Time PCR System (Applied Biosystems, U.S.A.). Gene arrangement of RAS1 was referenced using the Entrez System of the National Center for Biotechnology Information. PCR primer and TaqMan MGB probe were designed using Primer Express (Applied Biosystems). The results are shown as the relative expression against 18s rRNA.
Statistical Analysis Values are shown as meansϮstan-dard error, and statistical analysis of these data was performed using the Student's t-test. bicans were cultured in RPMI1640 medium supplemented with mucin at 37°C in 5% CO 2 . After 24 h incubation, C. albicans cells were photographed with an IX51 microscope (Fig. 1) . C. albicans suspended in RPMI1640 medium grew in hyphal form. When mucin was added to the medium, C. albicans grew in yeast form. As shown in Fig. 2 , the ratio of hyphal cells was 95.7Ϯ1.13% in the absence of mucin and no hyphal cells were observed in the presence of 1000 mg/ml mucin. To confirm the kinetics of the hyphal proliferation by mucin, we measured the ratio of the hyphal cells of C. albicans treated with mucin until 8 h (Fig. 3) . The ratio of hyphal cells began to decrease at 6 h in the mucin added group, and the ratio of hyphal cells was 50.0Ϯ1.41% with 8 h incubation.
Effect of Mucin on Growth Rate of C. albicans Growth rates of C. albicans treated with mucin were measured. As the result, the growth of C. albicans was not inhibit by the addition of less than 1000 mg/ml of mucin, however, 2000 mg/ml of mucin inhibited the growth (Fig. 4) . These re- Mucin (125, 250, 500, 1000 mg/ml) was added to C. albicans (1ϫ10 5 cells/ml in RPMI1640 medium), and incubated at 37°C, 5% CO 2 for 24 h. After incubation, the growth form of C. albicans was recorded using a camera attached to an IX51 microscope (ϫ400).
Fig. 2. Effect of Mucin on Growth Form of C. albicans
Mucin (125, 250, 500, 1000 mg/ml) was added to C. albicans (1ϫ10 5 cells/ml in RPMI1640 medium), and incubated at 37°C, 5% CO 2 for 24 h. After incubation, the ratio of hyphal cells was measured as described in Materials and Methods. The data represent mean values of three independent experiments.
Fig. 3. Kinetic Analysis of Mucin on Growth Form of C. albicans
Mucin (1000 mg/ml) was added to C. albicans (1ϫ10 5 cells/ml in RPMI1640 medium), and incubated at 37°C in 5% CO 2 . After incubation, the ratio of hyphal cells was measured as described in Materials and Methods. The data represent mean values of three independent experiments.
Fig. 4. Effect of Mucin on Growth Curves of C. albicans Treated with Mucin
C. albicans was incubated with mucin (1ϫ10 5 cells/ml in RPMI1640 medium) at 37°C in 5% CO 2 , and the growth rate was monitored at OD 620 and calculated as the number of cells. The data represent mean values of three independent experiments. sult indicated that the inhibition of hyphal formation was not due to the inhibition of germination by its antifungal activity.
Relative Expression of RAS1mRNA To confirm the effect of mucin on hyphal formation signal of C. albicans, the expression of RAS1mRNA was measured. As shown in Fig.  5 , RAS1mRNA increased after 5 h cultivation in the absence of mucin, whereas, the RAS1mRNA expression under conditions that induces hyphal growth was repressed in the presence of mucin. As the expression of EFG1 is controlled by RAS1, 6) EFG1mRNA in C. albicans cultivated with mucin was measured. The EFG1mRNA expression was also decreased at 50% by mucin (data not shown).
DISCUSSION
Patients treated with radiation therapy show decreased secretion of saliva. 10) In the patients, the frequency of oral candidasis is increased because saliva includes various antifungal factors, such as histatin 5 and mucin. 11) In general, C. albicans yeast cells bind to oral epithelial cells, then transform to hyphal cells to invade the tissue. 12) Adherence activity of C. albicans is higher in hyphae than yeast, 13) and adherence of C. albicans to mucus membrane is inhibited by saliva. 14) Thus, saliva may affect the transformation of C. albicans. However, there is no report that saliva controls the yeast to hyphal transformation of C. albicans. In this study, we exhibit that mucin inhibited the hyphal formation of C. albicans. C. albicans grew in hyphal form in RPMI1640 medium, however, mucin inhibited the hyphal growth (Figs.  1-3 ). These findings suggest that mucin is able to inhibit the hyphal transformation signal. However, the inhibition may be exhibited by cell death as mucin has antifungal activity. Thus, we measured the effect of mucin on the growth of C. albicans. As shown in Fig. 4 , less than 1000 mg/ml of mucin did not inhibit the growth of C. albicans, indicating that the inhibition of hyphal formation was not due to the inhibition of germination by its antifungal activity. Although mucin has antifungal activity, 9) 2000 mg/ml of mucin needed to inhibit the growth of C. albicans. To examine whether mucin controls the signal transduction pathway to regulate hyphal growth, the expression of RAS1mRNA in C. albicans treated with mucin was measured. RAS1 is a component of the hyphal formation signal, and the mRNA was increased after 5 h incubation in the control group (Fig. 5) . Mucin decreased the expression of RAS1mRNA, indicating that mucin inhibited the hyphal formation signals. The ratio of hyphal cells began to decrease at 6 h in the mucin addition group (Fig. 3) . The mucin acts on the log phase of the proliferation, and not to act in the lag phase. The result supported that the down-regulation of RAS1mRNA by mucin inhibited the hyphal proliferation. As mucin inhibits the hyphal formation of C. albicans, mucin may act as inhibiter of the oral Candida infection. Vol. 30, No. 2 C. albicans (1ϫ10 5 cells/ml in RPMI1640 medium) was incubated with mucin (1000 mg/ml) at 37°C in 5% CO 2 . After incubation, the cells were harvested and the relative expression of RAS1mRNA was measured as described in Materials and Methods. The data represent mean values of three independent experiments.
